for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Astrazeneca Says Lynparza Granted FDA Priority Review For Olympia

Nov 30 (Reuters) - AstraZeneca PLC:

* ASTRAZENECA PLC - LYNPARZA GRANTED FDA PRIORITY REVIEW FOR OLYMPIA

* ASTRAZENECA - LYNPARZA GRANTED PRIORITY REVIEW IN US FOR BRCA-MUTATED HER2-NEGATIVE HIGH-RISK EARLY BREAST CANCER Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up